From Data to Dialogue: A 56-Week Study of Inhaled Insulin in Pediatrics introduces inhaled insulin and its potential impact on students' daily diabetes management at school. It includes a brief orientation to using inhaled technosphere insulin, key findings from the 56-week INHALE-1 pediatric trial, and a Q&A addressing implications for school nursing practice.
This program is the second of a series of educational activities for school nurses focused on emerging technology in insulin delivery. See also Inhaled Insulin on the Horizon: What School Nurses Need to Know.